Ajanta Pharma Ltd - Company Profile
Powered by 
All the sales intelligence you need on Ajanta Pharma Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Ajanta Pharma Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Ajanta Pharma Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Ajanta Pharma Ltd (Ajanta Pharma) is a specialty pharmaceutical company. It is mainly engaged in the development, manufacturing, and marketing of branded generics and generic pharmaceutical products across various therapies such as Cardiology, Dermatology, Ophthalmology, Pain Management, Nephrology, Gynaecology, Anti-Diabetes, Antibiotic, Anti-Malarial, Respiratory, Paediatric, and General Health. The company's products are offered to patients through a network of CFAs, sales teams, distribution partners, and stockists in Africa, Asia, and North America. It operates a manufacturing unit in Gujarat, Maharashtra, Assam, and Madhya Pradesh. The company also supplies multivitamins, eye drops, cough syrups, and antibiotics to government bodies in India. Ajanta Pharma is headquartered in Mumbai, Maharashtra, India.
Headquarters
India
Address
Ajanta House, Charkop, Kandivli West, Mumbai, Maharashtra, 400067
Website
www.ajantapharma.com
Telephone
91 226 60609000
No of Employees
9,521
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
AJANTPHARM (NSE)
Revenue (2025)
$625.8M
17.3%
(2025 vs 2024)
EPS
XYZ
Net Income (2024)
XYZ
14.7%
(2024 vs 2023)
Market Cap*
$4.3B
Net Profit Margin (2025)
XYZ
-2.2%
(2024 vs 2023)
* As of and is in US$
Ajanta Pharma Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Branded | Valif |
| Generic Medicines: | Artefan |
| Diabetes | Met XL |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
Competitor Comparison
| Key Parameters | Ajanta Pharma Ltd | Aurobindo Pharma Ltd | Alembic Pharmaceuticals Ltd | Kopran Ltd | Syncom Formulations (India) Ltd |
|---|---|---|---|---|---|
| Headquarters | India | India | India | India | India |
| City | Mumbai | Hyderabad | Vadodara | Mumbai | Indore |
| State/Province | Maharashtra | Telangana | Gujarat | Maharashtra | Madhya Pradesh |
| No. of Employees | 9,521 | 9,107 | 16,571 | 800 | 554 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Mannalal B. Agrawal | Chairman | Executive Board | 1979 | - |
| Yogesh Mannalal Agrawal | Managing Director; Director | Executive Board | 2000 | - |
| Rajesh Mannalal Agrawal | Joint Managing Director; Director | Executive Board | 2013 | - |
| Arvind K. Agrawal | Chief Financial Officer | Senior Management | - | - |
| Madhusudan B. Agrawal | Vice Chairman; Director | Executive Board | 2025 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer